3.56BMarket Cap51.20P/E (TTM)
18.100High17.750Low606.47KVolume17.860Open18.080Pre Close10.89MTurnover0.88%Turnover Ratio48.43P/E (Static)198.84MShares22.41052wk High1.55P/B1.24BFloat Cap11.10052wk Low--Dividend TTM69.21MShs Float23.370Historical High--Div YieldTTM1.94%Amplitude8.750Historical Low17.958Avg Price1Lot Size
Life Time Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%, ...
No comment yet